Smith & Nephew (SNN) Change in Account Payables (2023 - 2024)
Smith & Nephew (SNN) reported Change in Account Payables of -$91.0 million for Q4 2024, up 47.09% on a YoY basis from -$61.9 million in Q1 2024, and up 47.09% quarter-over-quarter from -$172.0 million in Q4 2023.
Smith & Nephew (SNN) Change in Account Payables (2023 - 2024) Analysis & Trends
Smith & Nephew has reported Change in Account Payables for 2 years, with the latest figure at -$91.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -91.00 Mn |
| Dec 31, 2024 | -91.00 Mn |
| Dec 31, 2023 | -172.00 Mn |
| Dec 31, 2023 | -172.00 Mn |